Royal Bank of Canada Cuts Stock Position in Perrigo Company plc $PRGO

Royal Bank of Canada decreased its position in shares of Perrigo Company plc (NYSE:PRGO) by 73.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,873 shares of the company’s stock after selling 146,044 shares during the period. Royal Bank of Canada’s holdings in Perrigo were worth $578,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of PRGO. Price T Rowe Associates Inc. MD lifted its position in shares of Perrigo by 3.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock worth $244,634,000 after purchasing an additional 653,925 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Perrigo by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after purchasing an additional 1,101,154 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Perrigo by 291.9% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after buying an additional 5,828,076 shares during the period. State Street Corp increased its stake in Perrigo by 9.5% during the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after buying an additional 637,678 shares during the period. Finally, Thompson Siegel & Walmsley LLC lifted its holdings in Perrigo by 28.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock worth $64,848,000 after buying an additional 1,029,770 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Stock Up 0.0%

Shares of NYSE:PRGO opened at $14.25 on Tuesday. Perrigo Company plc has a fifty-two week low of $9.23 and a fifty-two week high of $24.49. The firm’s 50 day moving average price is $11.15 and its 200 day moving average price is $11.42. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. The stock has a market cap of $1.98 billion, a price-to-earnings ratio of -1.14, a price-to-earnings-growth ratio of 1.62 and a beta of 0.51.

Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.39 by $0.11. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the business posted ($0.06) EPS. The firm’s revenue was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities research analysts predict that Perrigo Company plc will post 2.2 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Friday, August 28th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 8.1%. Perrigo’s payout ratio is presently -9.27%.

Wall Street Analysts Forecast Growth

PRGO has been the subject of several research reports. Weiss Ratings upgraded shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Wall Street Zen upgraded Perrigo from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Perrigo presently has a consensus rating of “Hold” and an average target price of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.